---
created: '2026-02-13T19:04:38.633806Z'
description: A range of liver conditions affecting people who drink little to no alcohol,
  characterized by too much fat stored in liver cells.
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/condition/non-alcoholic-fatty-liver-disease/
slug: non-alcoholic-fatty-liver-disease
tags:
- condition
- gastroenterology
- metabolic
- liver
templateEngineOverride: njk
title: Non-alcoholic Fatty Liver Disease
type: condition
updated: '2026-02-13T19:04:38.633806Z'
---

{% raw %}
<h1>Non-alcoholic Fatty Liver Disease</h1>
<h2>Overview</h2>
<p>Non-alcoholic Fatty Liver Disease (NAFLD), recently renamed <strong>Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)</strong>, is the accumulation of excess fat in the liver. It is the most common chronic liver disease globally. It ranges from simple fatty liver (steatosis) to <strong>Non-Alcoholic Steatohepatitis (NASH)</strong>, which involves inflammation and liver cell damage, potentially progressing to cirrhosis and liver failure.</p>
<h2>Pathophysiology</h2>
<p>It is closely linked to <strong>insulin resistance</strong> and metabolic syndrome. Excess free fatty acids and carbohydrates are converted to triglycerides in the liver.</p>
<!-- NEO4J_CONTENT_START -->
<h2>Relationships</h2>
<h3>Related</h3>
<ul>
<li>→ <a href="/garden/dev_admin/condition/non-alcoholic-fatty-liver-disease/" class="internal-link">Non-alcoholic_Fatty_Liver_Disease</a> (entity)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:47:48.085665'
source: obsidian
</code></pre>
<ul>
<li>→ <a href="/garden/dev_admin/condition/non-alcoholic-fatty-liver-disease/" class="internal-link">Non-alcoholic_Fatty_Liver_Disease</a> (condition)</li>
</ul>
<pre><code class="language-yaml">last_modified: '2026-01-26T06:03:51.041127'
source: obsidian
</code></pre>
<!-- NEO4J_CONTENT_END -->
<h2>Relationships</h2>
<p>ASSOCIATED_WITH_CONDITION::<a class="internal-link is-unresolved" href="/404">Obesity</a><br />
ASSOCIATED_WITH_CONDITION::<a class="internal-link is-unresolved" href="/404">Type 2 Diabetes</a><br />
ASSOCIATED_WITH_CONDITION::<a href="/garden/dev_admin/condition/metabolic-syndrome/" class="internal-link">Metabolic Syndrome</a><br />
ASSOCIATED_WITH_CONDITION::<a class="internal-link is-unresolved" href="/404">Cirrhosis</a> - Potential end stage.<br />
AFFECTS_ORGAN::<a class="internal-link is-unresolved" href="/404">Liver</a><br />
IMPROVED_BY_INTERVENTION::<a class="internal-link is-unresolved" href="/404">Weight Loss</a><br />
IMPROVED_BY_INTERVENTION::<a class="internal-link is-unresolved" href="/404">Low Carbohydrate Diet</a><br />
ASSOCIATED_WITH_BIOMARKER::<a href="/garden/dev_admin/biomarker/alt/" class="internal-link">ALT</a> - Liver enzyme often elevated.<br />
ASSOCIATED_WITH_BIOMARKER::<a href="/garden/dev_admin/biomarker/ast/" class="internal-link">AST</a></p>
<h2>References</h2>
<ul>
<li>Chalasani, N., et al. (2018). The diagnosis and management of nonalcoholic fatty liver disease. Hepatology.</li>
<li>Younossi, Z. M., et al. (2016). Global epidemiology of nonalcoholic fatty liver disease. Hepatology.</li>
<li>EASL. Clinical Practice Guidelines on NAFLD.</li>
</ul>

{% endraw %}